comparemela.com

Latest Breaking News On - Soumit roy - Page 2 : comparemela.com

Buy Rating for Cassava Sciences: Rapid Alzheimer s Trials Progress and Strong Financial Health

Cassava Sciences (SAVA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy.

Rain Therapeutics Inc (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

vimarsana © 2020. All Rights Reserved.